Saturday , May 7 2016

ADVISORY BOARD

Anne Peters
MD, CDE
anne_peters1
David L. Joffe
BSPharm, CDE, FACA

(Editor in Chief)
Dave_Joffe
Joy Pape
MSN, FNP-C, CDE, WOCN, CFCN, FAADE

(Medical Editor)
joy_pape
Louis J. Aronne
MD, FACP
louis_aronne
Maria Emanuel Ryan
PhD
maria_ryan
Paul Chous
MA, OD
paul_chous
R. Keith Campbell
Professor, B.Pharm, MBA, CDE
keith_campbell
Stanley Schwartz
MD, FACP, FACE
stanley_schwartz
aaron_vinik Aaron I. Vinik
MD, PhD, FCP, MACP
caroline-apovian Caroline Apovian
MD
george_bakris George Bakris
MD
lawrence_lavery Lawrence A. Lavery
michael_cohen Michael R. Cohen
RPh, MS, ScD, FASHP
bernstein-small Richard K. Bernstein
MD, FACE, FACN, FACCWS
Sheri-Colberg-image Sheri Colberg
PhD, FACSM
steve-freed Steve Freed
RPh, CDE

(Publisher)

More information on Advisory Board members.


Read Testimonials from subscribers like you!



The Mission of Diabetes In Control is to be the world leader of current and accurate on-line diabetes information for medical professionals, and to promote increased understanding of the care and treatment of diabetes, ultimately helping the medical professional to empower the patient to better self-care.



Goals:

→ To provide the most current information on new drugs, therapies, and devices

→ To provide information on current studies and results

→ To provide trials for participation in new therapies, educational programs, meters, and other devices

→ To promote certification for diabetes educators

→ To provide current information on the standards of care

→ To provide methods for medical professionals to take responsibility for patient outcomes

→ To promote the team approach in diabetes care

→ To provide methods to empower the patient to better self-care



Letter to subscribers:

Diabetes is an epidemic, and there is great interest from the corporate world to bring new products and treatments to market. There are over 4900 studies going on for new drugs, appliances and treatments for diabetes. The information that is available is astronomical.


Since 1995 the medical industry has introduced more than 8 new drugs and insulins, 50 new meters, and pumps and countless over the counter aids. There will be over 20 new drugs submitted to the FDA for diabetes within the next 5 years.


It is crucial for medical professionals to have the most current information available. Because 98% of diabetes management has to come from the patient, if we can make it easier for them, they will have more success in controlling their diabetes.


In addition, the shift to outcomes-based diabetes management has put an extra strain on our time and increased our need for knowledge.


Since we are all so busy it makes it very difficult, almost impossible, to stay current on the new approaches, medications, meters, etc, for our patients.


We are offering you a free newsletter. This e-newsletter for diabetes educators and medical professionals will help keep you informed about the new treatments, devices and studies that can make a difference for your diabetic patients to self-manage their diabetes.